Chronic eosinophilic leukemias and the myeloproliferative variant of the hypereosinophilic syndrome

被引:51
作者
Bain, Barbara J. [1 ]
Fletcher, Sarah H. [1 ]
机构
[1] St Marys Hosp, Imperial Coll Fac med, Dept Haematol, London W2 1NY, England
关键词
D O I
10.1016/j.iac.2007.06.001
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Among patients with hypereosinophilia, a myeloproliferative variant is recognized. In many of these patients a diagnosis of eosinophilic leukemia can be made. The molecular mechanism is often a fusion gene, incorporating part of PDGFRA or PDGFRB, encoding anaberrant tyrosine kinase. Prompt diagnosis of such cases is important since specific tyrosine kinase inhibitor therapy is indicated.
引用
收藏
页码:377 / +
页数:13
相关论文
共 57 条
[1]   ACUTE MYELOBLASTIC-LEUKEMIA (M2) WITH TRANSLOCATION(7-11) FOLLOWED BY MARKED EOSINOPHILIA AND ADDITIONAL ABNORMALITIES OF CHROMOSOME-5 [J].
ABE, A ;
TANIMOTO, M ;
TOWATARI, M ;
MATSUOKA, A ;
KITAORI, K ;
KATO, H ;
TOYOZUMI, H ;
TAKEO, T ;
ADACHI, K ;
EMI, N ;
KAWASHIMA, K ;
SAITO, H .
CANCER GENETICS AND CYTOGENETICS, 1995, 83 (01) :37-41
[2]   Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta [J].
Apperley, JF ;
Gardembas, M ;
Melo, JV ;
Russell-Jones, R ;
Bain, BJ ;
Baxter, J ;
Chase, A ;
Chessells, JM ;
Colombat, M ;
Dearden, CE ;
Dimitrijevic, S ;
Mahon, FX ;
Marin, D ;
Nikolova, Z ;
Olavarria, E ;
Silberman, S ;
Schultheis, B ;
Cross, NCP ;
Goldman, JM .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) :481-487
[3]   Eosinophilic leukemia and idiopathic hypereosinophilic syndrome are mutually exclusive diagnoses [J].
Bain, BJ .
BLOOD, 2004, 104 (12) :3836-3836
[4]  
Bain BJ, 1996, BRIT J HAEMATOL, V95, P2
[5]   The t(4;22)(q12;q11) in atypical chronic myeloid leukaemia fuses BCR to PDGFRA [J].
Baxter, EJ ;
Hochhaus, A ;
Bolufer, P ;
Reiter, A ;
Fernandez, JM ;
Senent, L ;
Cervera, J ;
Moscardo, F ;
Sanz, MA ;
Cross, NCP .
HUMAN MOLECULAR GENETICS, 2002, 11 (12) :1391-1397
[6]   8pII myeloproliferative syndrome with a novel t(7;8) translocation leading to fusion of the FGFRI and TIFI genes [J].
Belloni, E ;
Trubia, M ;
Gasparini, P ;
Micucci, C ;
Tapinassi, C ;
Confalonieri, S ;
Nuciforo, P ;
Martino, B ;
Lo-Coco, F ;
Pelicci, PG ;
Di Fiore, PP .
GENES CHROMOSOMES & CANCER, 2005, 42 (03) :320-325
[7]   Complete remission of TEL-PDGFRB-induced myeloproliferative disease in mice by receptor tyrosine kinase inhibitor SU11657 [J].
Cain, JA ;
Grisolano, JL ;
Laird, AD ;
Tomasson, MH .
BLOOD, 2004, 104 (02) :561-564
[8]   PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder [J].
Chen, J ;
DeAngelo, DJ ;
Kutok, JL ;
Williams, IR ;
Lee, BH ;
Wadleigh, M ;
Duclos, N ;
Cohen, S ;
Adelsperger, J ;
Okabe, R ;
Coburn, A ;
Galinsky, I ;
Huntly, B ;
Cohen, PS ;
Meyer, T ;
Fabbro, D ;
Roesel, J ;
Banerji, L ;
Griffin, JD ;
Xiao, S ;
Fletcher, JA ;
Stone, RM ;
Gilliland, DG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (40) :14479-14484
[9]   HYPEREOSINOPHILIC SYNDROME - ANALYSIS OF 14 CASES WITH REVIEW OF LITERATURE [J].
CHUSID, MJ ;
DALE, DC ;
WEST, BC ;
WOLFF, SM .
MEDICINE, 1975, 54 (01) :1-27
[10]   A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome [J].
Cools, J ;
DeAngelo, DJ ;
Gotlib, J ;
Stover, EH ;
Legare, RD ;
Cortes, J ;
Kutok, J ;
Clark, J ;
Galinsky, I ;
Griffin, JD ;
Cross, NCP ;
Tefferi, A ;
Malone, J ;
Alam, R ;
Schrier, SL ;
Schmid, J ;
Rose, M ;
Vandenberghe, P ;
Verhoef, G ;
Boogaerts, M ;
Wlodarska, I ;
Kantarjian, H ;
Marynen, P ;
Coutre, SE ;
Stone, R ;
Gilliland, DG .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (13) :1201-1214